Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BioScrip Inc Reaffirms FY 2013 Revenue Guidance; Lowers FY 2013 EBITDA Guidance


Wednesday, 6 Nov 2013 05:00pm EST 

BioScrip Inc announced that for fiscal 2013, it expects revenue to be in the range of $830.0 million to $850.0 million and believes its Adjusted EBITDA to be in the range of $50.0 million to $52.0 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $839 million and EBITDA of $55.0 million for fiscal 2013. 

Company Quote

7.21
-0.26 -3.48%
17 Apr 2014